Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neuroimmune mechanisms of psychostimulant and opioid use disorders
Rebecca S. Hofford, Scott J. Russo, Drew D. Kiraly
European Journal of Neuroscience (2018) Vol. 50, Iss. 3, pp. 2562-2573
Open Access | Times Cited: 84

Showing 1-25 of 84 citing articles:

Gut microbiota–brain axis in depression: The role of neuroinflammation
Anelise S. Carlessi, Laura A. Borba, Alexandra I. Zugno, et al.
European Journal of Neuroscience (2019) Vol. 53, Iss. 1, pp. 222-235
Open Access | Times Cited: 188
Transcriptional Alterations in Dorsolateral Prefrontal Cortex and Nucleus Accumbens Implicate Neuroinflammation and Synaptic Remodeling in Opioid Use Disorder
Marianne L. Seney, Sam-Moon Kim, Jill R. Glausier, et al.
Biological Psychiatry (2021) Vol. 90, Iss. 8, pp. 550-562
Open Access | Times Cited: 113
A potential role for the gut microbiome in substance use disorders
Katherine Meckel, Drew D. Kiraly
Psychopharmacology (2019) Vol. 236, Iss. 5, pp. 1513-1530
Open Access | Times Cited: 127
Oxidative Stress and Neuroinflammation as a Pivot in Drug Abuse. A Focus on the Therapeutic Potential of Antioxidant and Anti-Inflammatory Agents and Biomolecules
Pablo Berríos‐Cárcamo, Mauricio Quezada, Marı́a Elena Quintanilla, et al.
Antioxidants (2020) Vol. 9, Iss. 9, pp. 830-830
Open Access | Times Cited: 71
Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities
Mark D. Namba, Jonna M. Leyrer‐Jackson, Erin K. Nagy, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 56
Sex-dependent associations between addiction-related behaviors and the microbiome in outbred rats
Veronica L. Peterson, Jerry B. Richards, Paul Meyer, et al.
EBioMedicine (2020) Vol. 55, pp. 102769-102769
Open Access | Times Cited: 57
Neuroimmune Mechanisms of Opioid Use Disorder and Recovery: Translatability to Human Studies, and Future Research Directions
Eduardo R. Butelman, Rita Z. Goldstein, Chinwe A. Nwaneshiudu, et al.
Neuroscience (2023) Vol. 528, pp. 102-116
Open Access | Times Cited: 21
Microbial short-chain fatty acids regulate drug seeking and transcriptional control in a model of cocaine seeking
Katherine Meckel, Sierra Simpson, Arthur Godino, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 2, pp. 386-395
Open Access | Times Cited: 17
Neurobiological Theories of Addiction: A Comprehensive Review
Carmen Ferrer‐Pérez, Sandra Montagud-Romero, M. Carmen Blanco-Gandía
Psychoactives (2024) Vol. 3, Iss. 1, pp. 35-47
Open Access | Times Cited: 7
Bacteroides uniformis CECT 7771 Modulates the Brain Reward Response to Reduce Binge Eating and Anxiety-Like Behavior in Rat
Ana Agustí, Isabel Campillo, Tiziano Balzano, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 10, pp. 4959-4979
Open Access | Times Cited: 40
Inflammatory Biomarkers in Addictive Disorders
Álvaro Morcuende, Francisco Navarrete, Elena Nieto, et al.
Biomolecules (2021) Vol. 11, Iss. 12, pp. 1824-1824
Open Access | Times Cited: 33
Comparative Analysis of Blood MMP-9 Concentration in Alcohol- and Opioid-Addicted Patients
Tamar Kartvelishvili, Nelly Sapojnikova, Nino Asatiani, et al.
Diseases (2025) Vol. 13, Iss. 2, pp. 30-30
Open Access
Antibody Immunotherapies for Personalized Opioid Addiction Treatment
Eric H. Rosenn, Miriam Korlansky, Shahin Benyaminpour, et al.
Journal of Pharmacology and Experimental Therapeutics (2025) Vol. 392, Iss. 4, pp. 103522-103522
Closed Access
Buprenorphine's Effect on the Human Immune System and Inflammation
Sunny Shin, Rachel Branning, Michele T McGinnis, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 3
Open Access
Neuroglia in substance use disorders
Emily M. Castro, Shahrdad Lotfipour, Frances M. Leslie
Handbook of clinical neurology (2025), pp. 347-369
Closed Access
Potential roles for microglia in drug addiction: Adolescent neurodevelopment and beyond
Maricela X. Martinez, Stephen V. Mahler
Journal of Neuroimmunology (2025), pp. 578600-578600
Closed Access
Microbiome and substances of abuse
M. Salavrakos, Sophie Leclercq, Philippe de Timary, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 105, pp. 110113-110113
Open Access | Times Cited: 33
A Glitch in the Matrix: The Role of Extracellular Matrix Remodeling in Opioid Use Disorder
Madelyn H. Ray, Benjamin R. Williams, Madeline K. Kuppe, et al.
Frontiers in Integrative Neuroscience (2022) Vol. 16
Open Access | Times Cited: 20
Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse
Ying Han, Lu Cao, Kai Yuan, et al.
Neuroscience Bulletin (2022) Vol. 38, Iss. 11, pp. 1365-1382
Open Access | Times Cited: 19
Transcriptional and epigenetic regulation of microglia in substance use disorders
Samara J. Vilca, Alexander V. Margetts, Tate A. Pollock, et al.
Molecular and Cellular Neuroscience (2023) Vol. 125, pp. 103838-103838
Open Access | Times Cited: 11
Methamphetamine and the Synthetic Cathinone 3,4-Methylenedioxypyrovalerone (MDPV) Produce Persistent Effects on Prefrontal and Striatal Microglial Morphology and Neuroimmune Signaling Following Repeated Binge-like Intake in Male and Female Rats
Erin K. Nagy, Paula F. Overby, Jonna M. Leyrer‐Jackson, et al.
Brain Sciences (2024) Vol. 14, Iss. 5, pp. 435-435
Open Access | Times Cited: 4
The role of the gut microbiome in opioid use
Michelle Ren, Shahrdad Lotfipour
Behavioural Pharmacology (2019) Vol. 31, Iss. 2&3, pp. 113-121
Open Access | Times Cited: 33
Contributions of neuroimmune and gut-brain signaling to vulnerability of developing substance use disorders
Kelsey E. Lucerne, Aya Osman, Katherine Meckel, et al.
Neuropharmacology (2021) Vol. 192, pp. 108598-108598
Open Access | Times Cited: 25
Extended access to fentanyl vapor self-administration leads to addiction-like behaviors in mice: Blood chemokine/cytokine levels as potential biomarkers
Renata C.N. Marchette, Erika R. Carlson, Nadia Said, et al.
Addiction Neuroscience (2022) Vol. 5, pp. 100057-100057
Open Access | Times Cited: 17
Clinical and Preclinical Evidence for Gut Microbiome Mechanisms in Substance Use Disorders
Rebecca S. Hofford, Drew D. Kiraly
Biological Psychiatry (2023) Vol. 95, Iss. 4, pp. 329-338
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top